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Efforts toward the First Enantioselective Total Synthesis of Praziquantel and 
 
 Synthetic Model Studies on Ecteinascidin 743 by Novel Aromatic C-H Insertion  
 
Methodology 
 
Chiliu Chen 
ABSTRACT 
 
The thesis is composed of three chapters.  The aim of this thesis is to apply the 
novel dirhodium perfluorobutyrate-catalyzed intramolecular aromatic C-H insertion 
methodology to the enantioselective total synthesis of praziquantel and synthetic model 
studies on ecteinascidin 743, which belongs to the important tetrahydroisoquinoline 
family. 
The first introductory chapter deals with the biological significance and previous 
synthetic methodologies.  Our novel methodology is based on dirhodium 
perfluorobutyrate-catalyzed intromolecular aromatic C-H insertion reaction, which is 
crucial in the pivotal carbon-carbon bond formation when constructing isoquinolone 
moiety, which is ubiquitous in numerous natural products of significant biological and 
pharmacological activities. 
The second chapter takes on the first enantioselective total synthesis of 
praziquantel, an antihelmintic drug.  Praziquantel is used worldwide to treat 
schistosomiasis, which has tremendous impact on the global fight on this disease 
affecting 150 million people.  We believe this is the first asymmetric total synthesis to 
date, which is distinct from previous racemic syntheses reported.  We also shed light on 
 v 
the mechanistic aspect of this key reaction to rationalize the superb regioselectivity and 
stereoselectivity achieved. 
The third chapter explores the synthetic model studies on ecteinascidin 743, a 
tetrahydroisoquinolone family natural product with significant antitumor and 
antimicrobial activities.  Several different synthetic routes were attempted, including the 
N-Methyl and the N-Boc routes, and the results achieved contributed significantly to our 
final synthetic plan of the target molecule. 
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Chapter One 
Introduction 
 The antitumor antibiotics belonging to the tetrahydroisoquinoline family have 
been investigated thoroughly over the past 25 years starting with the isolation of 
naphthyridinomycin in 1974.  To date, 55 natural products in this family have been 
isolated1.  Due to their stereochemically intricate structure, potent antitumor, 
antimicrobial activities, and enormous potential as promising drug candidates, they have 
become one of the most sought-after synthetic targets of a number of research groups.  
Figure 1-01 shows various natural products possessing tetrahydroisoquinoline moiety. 
 
Figure 1-01: Various Natural Products 
N
N Me
H OH
H
AcO
Me
S
O
NH
HO
MeO
O HO
OMe
Me
O
O
Ecteinascidin 743
(anticancer)
OH
H
MeO
OMe
N
N
O
H
Praziquantel
(S)-calycotomine
NH
O
 
 
 Although the syntheses of tetrahydroisoquinolines have been known for almost a 
century, chiral syntheses of tetrahydroisoquinolines have been rarely reported, and still 
remain a daunting challenge to organic chemists. 
 The primary pathway employed in the past of synthesizing this family of 
compounds is via Pictet-Spengler approach and its variants, as shown in Figure 1-02.  
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One of the most serious drawbacks arising from the intermolecular Pictet-Spengler 
reaction is its nonstereoselectivity, usually resulting in different diastereomers even under 
mild conditions2.  For instance, A1, which possesses one stereogenic center, would be 
converted into different diastereomers A2 and A3 under the intermolecular Pictet-
Spengler approach.  Also shown in Figure 1-02, alternatively, E.J.Corey achieved 
stereoselectivity, converting A4 to a single stereoisomer A5 of tetrahydroisoquinoline via 
intramolecular Pictet-Spengler approach3, but regioselectivity was compromised. 
 
Figure 1-02: Pictet-Spengler Approach 
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 Aromatic C-H insertion has been investigated by numerous research groups with 
mediocre results.4  The main hurdle encountered was the formation of side product 
cycloheptatriene A7, when aromatic C-H insertion was carried out with diazo precursor 
A6.  Formation of cycloheptatriene can be explained by cyclopropanation followed by 
 3 
ring expansion, as shown in Figure 1-03. 
 
Figure 1-03: Formation of Cycloheptatriene 
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 Employing diazo precursors, electrophilic aromatic substitution is another general 
route to gain access to the heterocyclic compounds.  For example, in the presence of 
nafion-H(an acid), electrophilic aromatic substitution of diazo precursors such as A8 
gives rise to the formation of indole A9, along with β-lactam A10.5 
 
Figure 1-04: Formation of Indole via Electrophilic Aromatic Substitution 
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 Isoquinolone formation via electrophilic aromatic substitution of diazo precursors 
such as A11 is also known, as shown in Figure 1-05.  However, the harsh conditions 
employed and concomitant regioisomer formations often pose serious problems.6 
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Figure 1-05: Formation of Isoquinolones via Electrophilic Substitution 
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 The drawbacks of previous methodologies were tackled by our investigation of 
novel Rh (II) catalyzed formal aromatic C-H insertion methodology and its applications 
to the first enantioselective synthesis of praziquantel and synthetic model studies on 
Ecteinascidin 743. 
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Chapter Two 
Efforts toward the First Enantioselective Total Synthesis of Praziquantel 
 
Introduction 
 
 Praziquantel is a well-known effective antihelmintic drug,1 used worldwide in the 
treatment of schistosomiasis.  Current stastistics suggest that 150 million people are 
infected with schistosomiasis,2 and praziquantel plays crucial role in curbing this disease.   
 Although several synthetic strategies 3 have emerged in literature, the results are 
still a far cry from being ideal, as shown in Figure 2-01.  Original synthesis of 
praziquantel was achieved by the formation of piperazine ring from 1-aminomethyl-
tetrahydroisoquinoline ring B2, the main disadvantage of this synthetic strategy was the 
requirement of a catalytic hydrogenation step with high pressure (ca. 100 atm) to 
construct the tetrahydroisoquinoline B2 from isoquinoline 4.  Another strategy employed 
hydroxypiperazinones B3, which were prepared by the partial reduction of piperazine-2, 
6-dione, to form an isoquinoline ring system 5, however, multi-step synthetic sequences 
or vigorous reaction conditions were required. 
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Figure 2-01: Previous Synthetic Strategies 
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 Predicated on our investigation of Rh (II) catalyzed intramolecular C-H insertion 
leading to regioselective and stereoselective formation of γ-lactams,6 we decided to 
expand this methodology to the construction of isoquinolones, in which crucial C-C bond 
formation would involve intramolecular aromatic C-H insertion.   
 9 
Results and Discussion 
 
 Our synthetic strategy of chiral praziquantel took advantage of diazo precursor 
that can be easily obtained from chiral L-alpha-phenylglycine B4, as shown in figure 2-
02.  We expected that the electrophilic metallocarbenoid derived from diazo precursor 
would lead to the intramolecualr aromatic C-H insertion product B6 by virtue of being 
less reactive, due to the elegant installation of α-phenylsulfonyl group which fine-tunes 
the reactivity of the metallocarbenoid center.  In addition, N, O-ketal ring would provide 
the requisite rigidity to the system so as to prevent the formation of regioisomers.  The 
key reactions in our novel synthesis of chiral praziquantel include: intramolecular 
aromatic C-H insertion of diazo precursor B5, coupling of secondary amine B7 with 2-
(Cyclohexylcarbonylamino) acetic acid, and final intramolecular cyclization. 
 
Figure 2-02: Retrosynthetic Analysis of Chiral Praziquantel 
 
CO2H
NH2
PhO2S N
O
N2
O
N
O
O
PhO2S
N
N
O
O
H
N
H
N
O
OOMs
NH
OTBDMS
B4 B5 B6
B7B8B9
Cyclization Coupling
Aromatic
C-H InsertionDiazo Transfer
H H
H
 
 10 
 
Isoquinolone formation by Intramolecular Aromatic C-H Insertion 
 We launched our synthesis of praziquantel with chiral L-alpha-phenylglycine.  
Reduction of L-alpha-phenylglycine B10 by LAH in THF afforded L-alpha-
phenylglycinol B11, followed by ketalization to give N, O-ketal B12.  N-acylation of 
secondary amine with α-bromoacetyl bromide followed by the treatment with 
benzenesulfinic acid sodium salt afforded α-phenylsulfonylacetamide B13.  Diazo 
transfer by p-ABSA and DBU yielded α-diazo-α-phenylsulfonylacetamide B14, which 
underwent intramolecular aromatic C-H insertion smoothly with the assistance of catalyst 
dirhodium perfluorobutyrate in refluxing dichloromethane to give isoquinolone B15 as a 
single diastereomer, as shown in figure 2-03.  The stereochemistry of the newly formed 
stereogenic center was unequivocally determined by X-ray crystallography. 
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Figure 2-03: Isoquinolone Formation by Intramolecular Aromatic C-H Insertion 
 
CO2H
NH2 LiAlH4
THF
NH2
OH OHNAcetone:DCE (1:1)
reflux for 8h
1) BrCH2COBr
0°C to r.t.
TEA, CH2Cl2
2) PhSO2Na, DMF
ON
PhO2S
O
reflux for 8h
ON
PhO2S
O
N2
p-ABSA, DBU
CH3CN, 0°C
N
O
O
PhO2S
H
cat. Rh2(pfb)4
CH2Cl2, reflux for 8h
quantitative yield
quantitative yield 70%, for two steps
90%
90%
B10 B11 B12 B13
B14B15  
 
 One of the important issues of this novel methodology is the mechanism of the 
reaction.  In order to rule out the possibility that the reaction proceeds via electrophilic 
aromatic substitution, reactions were carried out using different protic acids, also the 
electron-donating 3-OMe group was installed to further enhance the electron density of 
the aromatic ring.  Use of 10 mol% protic acid at higher temperature led to the formation 
of isoquinolone in small amount, but it was accompanied by considerable product 
decomposition (entry 1). However, the reaction did not proceed at all in low boiling 
solvents like dichloromethane (entry 2). Furthermore, the reaction did not go to 
completion when a smaller amount of catalyst was used (entry 3), as shown in Table 2-
01. 
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Table 2-01: Effect of Protic Acids 
 
ON
PhO2S
O
N2
N
O
O
PhO2S
OMe OMe
Yield
25%
conditions
10 mol% pfb
10 mol% pfb No reaction
solvent
CH2Cl2
2 mol% Rh2(OAc)4,  5 mol% pfb 63 %CH2Cl2
2 mol% Rh2(OAc)4 68 %CH2Cl2
C6H6
B16 B17
time
1 h
24 h
0.5 h
0.75 h
2 mol% Rh2(OAc)4,  5 mol% AcOH 92 %CH2Cl2 0.5 h
entry
1
2
3
4
5  
 
 Based on these results, we postulated that the reaction proceeded via formation of 
electrophilic rhodium carbenoid B19, which was then attacked by the electron-rich 
aromatic ring. The phenylsulfonyl group then rearranged itself into a more 
thermodynamically stable position, so as to make C-H and C-Rh bond syn-periplanar to 
each other, and hence facilitating hydrogen transfer, as shown in Figure 2-04. 
 13 
Figure 2-04: Mechanism of Formal Aromatic C-H Insertion 
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Coupling with 2-(Cyclohexylcarbonylamino) Acetic Acid 
 Dephenylsulfonylation followed by deketalization of isoquinolone B23 afforded 
acetate B25.  Amido acetate was then completely reduced to give amino alcohol B26.  In 
order to set the stage for the crucial coupling with 2-(cyclohexylcarbonylamino) acetic 
acid, the hydroxyl group of the amino alcohol has to be selectively protected over the 
amino group.  In the course of our synthesis, we first tried to protect the hydroxyl group 
with TBDMSCl and imidazole, only a trace amount of desired product was observed.  
The use of a more reactive silylating agent TBDMS triflate resulted in the protection of 
both amino and hydroxyl groups.  The selective protection problem was circumvented by 
fine-tuning the reactivity of the silylating agent.  Selective protection of the hydroxyl 
group was achieved by employing TBDMSCl in the presence of TEA to give the 
protected amino alcohol B27.  Finally, the crucial coupling of the protected amino 
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alcolhol B27 with 2-(cyclohexylcarbonylamino) acetic acid was accomplished on 
treatment with HOBT, EDCI, and TEA, as shown in Figure 2-05. 
 
Figure 2-05: Coupling with 2-(Cyclohexylcarbonylamino) Acetic Acid 
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Intramolecular Cyclization 
 TBDMS deprotection of the coupling product B28 by TBAF afforded alcohol 
B29, we were poised to explore the final intramolecular cyclization.  We considered that 
two competing factors would come into play to effect the final outcome of the 
intramolecular cyclization: the tendency to form six-membered ring would be the 
favorable factor, and the weak nucleophilicity of the amide nitrogen would be the 
unfavorable factor.  We tried to cyclize B29 by using methanesulfonyl chloride and TEA, 
but it failed to afford the desired intramolecular cyclization product praziquantel, as 
shown in Figure 2-06.  Efforts to clear the final hurdle of cyclization will be continued in 
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our research group. 
 
Figure 2-06: Intramolecular Cyclization 
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Conclusion 
 
 In conclusion, we have developed a novel and efficient methodology for the 
synthesis of isoquinolones via intramolecular aromatic C-H insertion.  The isoquinolone 
was obtained as a single regio- and diastereomer.  This methodology can be applied to 
construct various chiral isoquinolones, and these isoquinolones can be further 
functionalized to synthesize a slew of biologically important natural products. 
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Experimental Section 
 
General Methods 
 All experiments were performed under nitrogen atmosphere, using glassware 
dried by oven or flame.  All reagents were purchased from ACROS and Aldrich chemical 
Co. Dichloromethane was distilled over calcium hydride prior to use.  Analytical thin-
layer chromatography (TLC) was performed on precoated glass-backed 60 Å silica gel 
(0.25 mm thickness) and visualized with a 254 nm UV light.  TLC plates were further 
visualized with I2 and/or ninhydrin solution (0.4 gm in 100 ml n-butanol + 1 ml acetic 
acid). All reactions were worked up after the complete consumption of starting materials 
unless specified otherwise. Flash chromatography was carried out using silica gel 60Å 
(particle size 200 mesh). Unless otherwise stated, all NMR spectra were recorded on 250 
or 360 MHz Bruker spectrometers, using CHCl3 (δH = 7.26 ppm) or δC =  77.00 ppm) as 
an internal standard. 
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Formation of α-Diazo-α-(phenylsulfonyl)acetamide B14. 
Into a solution of 2-benzenesulfonyl-1-(2,2-dimethyl-4-phenyl-oxazolidin-3-yl)ethanone 
(359 mg, 1.00 mmol) in acetonitrile (5.00 ml, 0.2 M) were added successively ABSA 
(360 mg, 1.5 mmol, 1.5 eq.) and DBU (0.38 ml, 2.5 mmol., 2.5 eq.) and stirred under 
nitrogen atmosphere for 1.5 hrs at 0 °C. At the end of the reaction, the solvent was 
removed under reduced pressure and the residue was dissolved in diethyl ether. The 
organic layer was successively washed with 1 N NaOH followed by water. The organic 
layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure. 
The crude diazo compound was subjected to flash column chromatography to yield 
analytically pure diazo compound B14 (300 mg, 78%) as a yellow solid.  1H NMR (250 
MHz)  δ 1.50 (s, 3 H), 1.68 (s, 3 H), 3.67 (t, J = 8.5 Hz, 1 H), 4.22 (t, J = 7.1 Hz, 1 H), 
4.71 (t, J = 6.2 Hz, 1 H), 7.40 (m, 10 H). 13C NMR (62 MHz) δ 24.36, 61.48, 72.12, 
74.43, 97.38, 125.31, 127.63, 128.38, 128.81, 129.06, 133.48, 137.95, 141.67, 154.86. 
 19 
ON
PhO2S
O
N2
N
O
O
PhO2S
H
cat. Rh2(pfb)4
CH2Cl2, reflux for 8h
90%
B14 B15  
 
Formation of Isoquinolone B15 via Intramolecular Aromatic C-H Insertion of α-Diazo-α 
(phenylsulfonyl)acetamide B14. 
Rh2(pfb)4 (22 mg, 5 mol%) was added to a solution of α-diazo-α-(phenylsulfonyl)acetamide 
B14 (0.15 g, 0.41 mmol) in dry dichloromethane (17 mL, C = 0.025 M). The mixture was 
refluxed for 8 hrs under N2, cooled to r.t., and concentrated.  The residue was chromatographed 
to give isoquinolone B15 as a white crystal. (144 mg, 90%).  1H NMR (250 MHz) δ 1.45 (s, 3 
H), 1.62 (s, 3 H), 3.74 (ABX, JAB = 9.2 Hz, JAX = 8.4 Hz, 1 H), 4.53 (JABX, JAB = 9.2 Hz, JBX = 
6.3 Hz, 1 H), 4.86 (s, 1 H), 4.98 (dd, J1 = 6.2 Hz, J2= 10.1 Hz, 1 H ), 6.98 (m, 1 H), 7–7.77 (m, 8 
H).13C NMR (62 MHz) δ 23.21, 25.08, 58.16, 68.19, 74.49, 95.73, 123.96, 125.44, 128.32, 
129.04, 129.23, 129.69, 130.94, 134.97, 137.11, 157.69. 
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Formation of Dephenylsulfonated Isoquinolone B24  
S.M. B23 was dissolved in THF (C=0.2 M) at 0°C, then 6.0 eq. of activated zinc was 
added to the solution, followed by the addition of 2.0 eq. of titanium tetrachloride in 1M 
dichloromethane solution, kept vigorously stirring at 0°C for 30 min, and the ice bath was 
removed, and kept stirring at room temperature under nitrogen atmosphere for 4 h.  At 
the end of the reaction, a small amount of water was added to the reaction mixture, then 
extracted three times with dichloromethane, the organic layer was dried over anhydrous 
sodium sulfate and concentrated under reduced pressure.  The crude mixture was 
subjected to flash column chromatography to give the dephenylsulfonated isoquinolone 
B24 (95%) as a green solid.  1H NMR (250 MHz) δ 1.48 (s, 3 H), 1.67 (s, 3 H), 3.51 (q, 
J= 18.3 Hz, 2 H), 3.88 (t, J = 8.7 Hz, 1 H), 4.56 (t, J= 6.4 Hz, 1 H), 4.78 (m, 1 H), 6.92-
7.43 (m, 4 H). 13C NMR (62 MHz) δ 23.50, 25.40, 39.62, 57.60, 67.60, 77.24, 94.71, 
123.12, 126.68, 127.09, 127.85, 132.95, 133.17, 165.50. 
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Formation of Acetate B25 via Deketalization of the N, O-Ketal Ring  
Into S.M. B24, was added hydrobromic acid with acetic acid, kept vigorously stirring at 
room temperature for 8 h.  At the end of the reaction, air-blew most of the hydrobromic 
acid.  Then the brown reaction mixture was kept at 0°C, into which saturated sodium 
bicarbonate solution was added cautiously, and when the reaction mixture solution turned 
into weakly basic, extracted with ethyl acetate three times.  The organic layer was dried 
over anhydrous sodium sulfate and concentrated under reduced pressure.  The crude 
mixture was then subjected to flash column chromatography to give the pure acetate B25 
(70%) as a brown solid.  1H NMR (250 MHz)  δ 2.06 (s, 3 H), 3.55 (m, 2 H), 4.11 (m, 1 
H), 4.33 (dd, J1=3.8 Hz, J2=11.1Hz, 1 H), 4.73 (m, 1 H), 6.93-8.05 (m, 4 H). 13C NMR 
(62 MHz) δ 20.66, 35.59, 54.91, 67.90, 76.91, 125.98, 126.74, 127.96, 130.07, 131.61, 
170.52, 171.63. 
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Formation of Complete Reduction Product Amino Alcohol B26  
Acetate B25 was dissolved in THF (C=0.4 M) at 0°C, and then 4.0 eq. of lithium 
aluminum hydride was added to the solution, kept vigorously stirring at 0°C for 30 min, 
and then the ice bath was removed, and kept refluxing for 8h.  Let the reaction mixture 
cool down to room temperature, and then kept at 0°C, small amount of sodium sulfate 
decahydrate was added to quench the reaction.  The resulting reaction mixture was 
filtered by vacuum filtration, and the solid was washed three times with THF, the organic 
layer was dried over anhydrous sodium sulfate and concentrated under reduced pressure.  
The resulting mixture was subjected to flash column chromatography to give the amino 
alcohol B26 (85%) as a light yellow oil.  1H NMR (250 MHz) δ 2.74-2.79 (m, 2 H), 3.05-
3.10 (m, 2 H), 3.59-3.81 (m, 2 H), 4.01-4.05 (m, 1 H), 7.06-7.33 (m, 4 H). 
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Formation of TBDMS Protected Amino Alcohol B27  
Amino alcohol B26 was dissolved in anhydrous dichloromethane, 2.5 eq. of TEA was 
added, then 1.2 eq. of t-butyl-dimethylchlorosilane and catalytic amount of DMAP was 
added, and kept vigorously stirring at room temperature for 24 h.  At the end of the 
reaction, a small amount of water was added into the reaction mixture, and extracted with 
dichloromethane three times.  The organic layer was dried over anhydrous sodium sulfate 
and concentrated under reduced pressure, then the crude mixture was subjected to flash 
column chromatography to give the TBDMS protected amino alcohol B27 (80%) as a 
light yellow solid.  1H NMR (250 MHz)  δ 0.048 (d, J=7.6 Hz, 6 H), 0.88 (s, 9 H), 2.65-
2.81 (m, 2 H), 2.88-2.97 (m, 1 H), 3.16-3.20 (m, 1 H), 3.70-3.85 (m, 2 H), 4.03-4.05 (m, 
1 H), 7.10-7.56 (m, 4 H). 
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Formation of the Coupled Product B28 via Coupling Reaction of the TBDMS Protected 
Amino Alcohol with 2-(Cyclohexylcarbonylamino) Acetic Acid 
1.2 eq. of 2-(Cyclohexylcarbonylamino) acetic acid was dissolved in DMF (C=0.2 M), 
then 1.44 eq. of HOBt was added, followed by addition of 1.44 eq. of TEA, then addition 
of 1.44 eq. of EDCI, kept vigorously stirring for 1h, finally, the solution of TBDMS 
protected amino alcohol B27 (dissolved in small amount of DMF) was added to the 
reaction mixture.  The reaction mixture was kept vigorously stirring for 4h. At the end of 
the reaction, a small amount of water was added, and extracted with ethyl acetate three 
times, the organic layer was dried over anhydrous sodium sulfate and concentrated under 
reduced pressure, then the crude mixture was subjected to flash column chromatography 
to give the coupling product B28 as a white solid.  1H NMR (250 MHz)  δ -0.15 (d, J=8.3 
Hz, 6 H), -0.03 (d, J=10.6 Hz, 6 H), 0.68 (s, 9 H), 0.80 (s, 9 H), 1.22-2.15 (m, 11 H), 2.85 
(s, 2 H), 2.92 (s, 2 H), 3.52-4.38 (m, 5 H), 4.81-4.95 (m, 2 H), 7.06-7.97 (m, 4 H). 
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Chapter Three 
Synthetic Model Studies on Ecteinascidin 743 
 
Introduction 
 
 Ecteinascidin 743 is an extremely potent antitumor agent isolated from a marine 
tunicate, Ecteinascidia turbinate. 1  The isolation of the ecteinascidins was first reported 
by Rinehart et al. in 1990.  Ecteinascidin 743 is currently undergoing phase II clinical 
trials and attracting considerable attention due to its remarkable biological activities.  The 
mechanism of action of the ecteinascidins has been studied by several groups.  It has been 
shown that Ecteinascidin 743 has a similar structure to that of saframycin S, indicating 
that DNA alkylation should be indeed possible. 2  The alkylation takes place in the minor 
groove, as does alkylation with the saframycins.  The alkylated DNA substrate exhibits a 
bend or widening of the minor groove, presumably due to the C-subunit of the 
ecteinascidins.  The C-subunit, which is perpendicular to the rest of the molecule, makes 
the ecteinascidins unique from the saframycins, which are fairly flat.  It has been 
postulated that this bend in DNA disrupts DNA-protein binding and may be, in part, the 
source of the enhanced biological activities of the ecteinascidins.  The novelty of its 
structure, the meager availability from natural sources, and the unique mechanism of 
action 3 has made Ecteinascidin 743 a very attractive and important synthetic target, as 
shown in Figure 3-01. 
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Figure 3-01: Ecteinascidin 743 
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 The first total synthesis of Ecteinascidin 743 4 was accomplished by E. J. Corey in 
1996 employing the coupling of two optically active fragments as seen in their 
saframycin A synthesis.  Starting with hexacycle C1, a selective hydroxylation was 
accomplished using phenylselenic anhydride. Removal of the silyl ether followed by 
esterification with a diprotected cysteine derivative provided C2.  Elimination of the 
tertiary alcohol under Swern conditions allowed for cyclization of the thiol to form C3.  
Removal of the Alloc carbamate followed by transamination afforded α-keto lactone C4.  
The final three steps to Ecteinascidin 743 were the condensation of the homobenzylic 
amine C5 on the ketone followed by removal of the MOM group with TFA and finally 
conversion of the aminonitrile to the carbinolamine using silver nitrate and water, as 
shown in Figure 3-02. 
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Figure 3-02: Corey’s Total Synthesis of Ecteinascidin 743 
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 Carmen Cuevas’ group 5 was able to synthesize Ecteinascidin 743 in a 
semisynthetic fashion starting from cyanosafracin B 6, which is an antibiotic of bacterial 
origin, available through fermentation of the bacterial Pseudomonas fluorescens 7.  
Optimization of the fermentation process has allowed for the synthesis of cyanosafracin 
B on a kilogram scale, providing a robust, sophisticated, and cheap starting material for 
the synthesis of Ecteinascidin compounds, as shown in Figure 3-03. 
 30 
Figure 3-03: Cuevas’ Formal Synthesis of Ecteinascidin 743 
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 In 2002, Tohru Fukuyama’s group 8 accomplished an enantioselective total 
synthesis of Ecteinascidin 743.  Their synthesis features Ugi’s four-component 
condensation for a ready access to diketopiperazine C9, and the intramolecular Heck 
reaction of the cyclic enamide C10 to give tricycle C11, as shown in Figure 3-04. 
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Figure 3-04: Fukuyama’s Synthesis of Ecteinascidin 743 
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Results and Discussion 
 
 Despite some progress made in the total synthesis of ecteinascidin 743, there is 
still of vast interest to find a more efficient synthesis, and we have felt that a convergent 
synthetic strategy may become a more practical solution.  Efficient synthesis of chiral 
building blocks is crucial for a convergent synthetic strategy to succeed, and we are 
ambitious to apply our novel intramolecular aromatic C-H insertion methodology to serve 
this aim.  Ecteinascidin 743 is composed of three tetrahydroisoquinoline moieties, which 
resemble the three building blocks designed in our synthetic strategy, the three fragments 
C12, C13, and C14 will be prepared in an asymmetric manner, and coupled in the order 
of (C12 + C13) + C14 to secure the Ecteinascidin 743 skeleton, as depicted in Figure 3-
05.   
 
Figure 3-05: Jung’s Synthetic Strategy of Ecteinascidin 743 
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 One of the strategies we are currently pursuing is the late stage cyclization of 
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diazo precursor. In order to achieve this goal, we have coupled pyroglutamic acid 
derivative to phenylglycine methyl ester. Currently, we are investigating various diazo 
transfer conditions as well as different pyroglutamic acid derivatives to achieve optimum 
conditions for fused ring system. 
 The first route attempted in our synthetic model studies on Ecteinascidin 743 was 
with the N-methyl derivative of pyroglutamic acid, as shown in Figure 3-06. 
 
Figure 3-06: N-Methyl Derivatives of Pyroglutamic Acid 
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Esterification of L-2-pyrrolidone-5-carboxylic acid with benzyl bromide afforded 
benzyl ester C13. N-methylation of pyrrolidone with iodomethane afforded the N-
methylated benzyl ester C14, hydrogenolysis of the benzyl ester with palladium on 
carbon afforded the resulting carboxylic acid C15. Generation of acid chloride in situ, 
followed by coupling with (S)-(+)-2-phenylglycine methyl ester hydrochloride, afforded 
the coupled methyl ester C16. Selective reduction of the coupled methyl ester with 
sodium borohydride: lithium chloride (1:1) afforded the alcohol C17.  Then we were 
poised to do the intramolecular cyclization to install the crucial oxazoline skeleton.  
Treatment of the alcohol C17 with methanesulfonyl chloride and TEA, followed by 
reluxing in sodium hydroxide in ethanol afforded the oxazoline C19 smoothly.  Next 
three steps were mainly functional group manipulations to install the phenylsulfonyl 
group to the oxazoline ring nitrogen, so as to set the stage for diazo transfer.  N-Acylation 
and in situ reduction of the resulting N-acylium ion with sodium borohydride afforded the 
reduced oxazoline C20 with N-(α-chloro)-acetyl group at the proper position.  The 
primary chloride C20 was treated with sodium iodide in acetone, namely, Finkelstein 
reaction, followed by treatment with benzenesulfinic acid sodium salt, afforded the 
phenylsulfone C22.  Frustratingly, several diazo transfer conditions failed to obtain the 
desired diazo transfer product C23, which was the requisite precursor for our next 
intramolecular C-H insertion, as shown in Figure 3-07. 
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Figure 3-07: Failure of Diazo Transfer 
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 The second route was with the N-Boc derivative of pyroglutamic acid, as shown 
in Figure 3-08. 
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Figure 3-08: N-Boc Derivatives of Pyroglutamic Acid 
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 Esterification of L-2-pyrrolidone-5-carboxylic acid by thionyl chloride in 
methanol afforded methyl ester.  N-Boc protection of pyrrolidone with di-tert-butyl 
dicarbonate afforded the N-Boc protected methyl ester C24.  Selective reduction of the 
resulting N-Boc protected amide with sodium borohydride afforded the N-Boc protected 
amino alcohol C25, conscientious monitoring and stringent control of temperature was 
crucial in achieving the desired selectively reduced amino alcohol, otherwise, side 
products may ensue, as shown in Figure 3-09. 
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Figure 3-09: Selective Reduction of N-Boc Protected Pyrrolidone Methyl Ester 
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 After we obtained the N-Boc protected amino alcohol C25, we were ready to do 
the elimination reaction.  Treatment of the amino alcohol C25 with trifluoroacetic 
anhydride and TEA in dichloromethane afforded the elimination product C26, followed 
by hydrolysis with sodium hydroxide in methanol gave the resulting carboxylic acid.  
Coupling of the carboxylic acid with (S)-(+)-2-phenylglycine methyl ester hydrochloride 
by treatment with HOBt, EDCI, and TEA in dichloromethane afforded the coupled 
methyl ester C28.  Selective reduction of the coupled methyl ester with sodium 
borohydride: lithium chloride (1:1) afforded the alcohol C29.  Then we were poised to do 
the intramolecular cyclization to install the crucial oxazoline skeleton.  Treatment of the 
alcohol C29 with methanesulfonyl chloride and TEA yielded the methanesulfonate C30, 
but the resulting intramolecular cyclization failed to give the oxazoline C31 by reluxing 
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the methanesulfonate C30 in sodium hydroxide in ethanol. 
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Conclusion 
 
 In conclusion, we have developed a novel and efficient methodology for the 
construction of isoquinolones via intramolecular aromatic C-H insertion. Our audacious 
and pioneering research in this field will make huge impact on the ingenious syntheses of 
various natural products with tetrahydroisoquinoline skeletons, including saframycine, 
tetrazomine, and ecteinascidin 743, which are considered as possible anticancer drugs.  
The synthetic model studies on Ecteinascidin 743 helped explore new routes to apply the 
methodology to the fused ring system and gain insight on how to design a more suitable 
strategy to accomplish the total synthesis, especially when the intramolecular aromatic C-
H insertion would take place in the context of a big, complicated molecule with 
diabolical disposition of various functional groups.  We are dedicated to further refining 
and applying this novel methodology to the total syntheses of various natural products 
with tetrahydroisoquinoline skeletons.   
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Experimental Section 
 
General Methods 
 All experiments were performed under nitrogen atmosphere, using glassware 
dried by oven or flame.  All reagents were purchased from ACROS and Aldrich chemical 
Co. Dichloromethane was distilled over calcium hydride prior to use.  Analytical thin-
layer chromatography (TLC) was performed on precoated glass-backed 60 Å silica gel 
(0.25 mm thickness) and visualized with a 254 nm UV light.  TLC plates were further 
visualized with I2 and/or Ninhydrin solution (0.4 gm in 100 ml n-butanol + 1 ml acetic 
acid). All reactions were worked up after the complete consumption of starting materials 
unless specified otherwise. Flash chromatography was carried out using silica gel 60Å 
(particle size 200 mesh). Unless otherwise stated, all NMR spectra were recorded on 250 
or 360 MHz Bruker spectrometers, using CHCl3 (δH = 7.26 ppm) or δC =  77.00 ppm) as 
an internal standard. 
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Formation of Benzyl-(2S)-1-Pyroglutamate C13 
L-2-pyrrolidone-5-carboxylic acid C12 was dissolved in acetonitrile (C=0.2 M), and 1.1 
eq. of potassium carbonate was added, then 1.1 eq. of benzyl bromide was added 
dropwise, kept vigorously stirring under reflux for 8h. At the end of the reaction, 
acetonitrile was evaporated under reduced pressure, the resulting mixture was subjected 
to flash column chromatography to give the benzyl ester C13 (97%).  1H NMR (250 
MHz)  δ 2.17-2.44 (m, 4 H), 4.21 (dd, J1=5.4 Hz, J2=8.3 Hz, 1 H), 5.13 (s, 2 H), 5.93 (s, 1 
H), 7.24 (m, 5 H). 
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Formation of Benzyl-(2S)-1-Methyl Pyroglutamate C14 
Benzyl ester C13 was dissolved in THF (C=0.4 M) at 0°C, 1.2 eq. of sodium hydride was 
added, then 1.3 eq. of iodomethane was added dropwise, kept vigorously stirring for 2h.  
At the end of the reaction, THF was evaporated under reduced pressure. Into the resulting 
reaction mixture was added a small amount of water, and extracted with ethyl acetate 
three times, dried over anhydrous sodium sulfate, and concentrated under reduced 
pressure. The mixture was subjected to flash column chromatography to give the Benzyl-
(2S)-1-Methyl Pyroglutamate C14 (65%).  1H NMR (250 MHz)  δ 2.10-2.33 (m, 4 H), 
2.77 (s, 3 H), 4.07 (dd, J1=5.4 Hz, J2=8.3 Hz, 1 H), 5.14 (s, 2 H), 7.24 (m, 5 H). 
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Formation of 1-Methyl-(2S)-Pyroglutamic Acid C15 
Benzyl-(2S)-1-Methyl Pyroglutamate C14 was dissolved in Methanol (C=0.4 M), 
catalytic amount of palladium on carbon was added, then put into hydrogenator and 
subjected to hydrogenolysis for 12 h.  At the end of the reaction, the palladium on carbon 
was filtered out by vacuum filtration and washed with dichloromethane three times.  The 
organic layer was concentrated under reduced pressure to give the 1-Methyl-(2S) 
Pyroglutamic acid C15 in quantitative yield.  1H NMR (250 MHz)  δ 2.09-2.58 (m, 4 H), 
2.88 (s, 3 H), 4.14 (dd, J1=1.8 Hz, J2=8.2 Hz, 1 H). 
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Formation of the Coupled Product C16 via Coupling Reaction of 1-Methyl-(2S)- 
Pyroglutamic Acid C15 with (S)-(+)-2-Phenylglycine Methyl ester Hydrochloride 
The carboxylic acid C15 was dissolved in anhydrous dichloromethane (C=0.2 M), and 
1.1 eq. of oxalyl chloride was added, and kept vigorously stirring at room temperature for 
8 h to form the acid chloride.  1.2 eq. of (S)-(+)-2-phenylglycine methyl ester 
hydrochloride was dissolved in anhydrous dichloromethane (C=0.4 M), 3.5 eq. of TEA 
was added, and cooled to 0°C, followed by addition of of the acid chloride mixture.  The 
reaction mixture was kept vigorously stirring at 0°C for 4 h.  At the end of the reaction, a 
small amount of water was added, and extracted with dichloromethane three times, the 
organic layer was dried over anhydrous sodium sulfate and concentrated under reduced 
pressure, then the crude mixture was subjected to flash column chromatography to give 
the coupling product C16 (74%) as a white solid.  1H NMR (250 MHz)  δ 1.87-2.52 (m, 4 
H), 2.68 (s, 3 H), 3.63 (s, 3 H), 4.04 (m, 1 H, ), 5.49 (dd, J1=3.1 Hz, J2=7.2 Hz, 1 H), 
7.14-7.80 (m, 5 H). 
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Formation of the Reduction Product Phenylglycinol C17 
Methyl ester C16 was dissolved in THF (C=0.4 M) at 0°C, 3.0 eq. of lithium chloride was 
added, and the mixture was kept stirring at 0°C for 5 mins, then 3.0 eq. of sodium borohydride 
was added portionwise, and equal volume of methanol was added dropwise, and the mixture was 
kept vigorously stirring at 0°C for 5 h.  At the end of the reaction, solvents were evaporated 
under reduced pressure, into the white reaction mixture, a small amount of water was added, and 
extracted with ethyl acetate three times.  The organic layer was dried over anhydrous sodium 
sulfate, and concentrated under reduced pressure to give the reduced product phenylglycinol 
C17 (90%) as a white solid.   
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Formation of Oxazoline C19 via Intramolecular Cyclization 
The phenylglycinol C17 was dissolved in anhydrous dichloromethane (C=0.4 M), then 
cooled to -20°C, and 5.0 eq. of TEA was added, followed by the addition of 2.3 eq. of 
methanesulfonyl chloride, and kept vigorously stirring  for 4 h.  At the end of the 
reaction, a small amount of water was added, and extracted with dichloromethane three 
times, the organic layer was dried over anhydrous sodium sulfate and concentrated under 
reduced pressure.  The crude mixture was dissolved in ethanol (C=0.4M), and 5.0 eq. of 
sodium hydroxide was added, then kept refluxing for 30 mins.  At the end of the reaction, 
a small amount of water was added, and extracted with ethyl acetate three times, the 
organic layer was dried over anhydrous sodium sulfate and concentrated under reduced 
pressure to give the oxazoline C19 ( quantitative yield for two steps) as a light yellow oil.  
1H NMR (250 MHz)  δ 1.95-2.33 (m, 4 H), 2.82 (s, 3 H), 4.01-4.14 (m, 1 H), 4.26-4.31 
(m, 1 H), 4.57-4.63 (m, 1 H), 5.15-5.16 (m, 1 H), 7.11-7.30 (m, 5 H). 
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Formation of N-Iodoacetyl Oxazoline C21 via N-Acylation and Reduction, and Finkelstein 
Reaction 
The oxazoline C19 was dissolved in anhydrous THF (C=0.3 M), then cooled to -78°C, 
and 1.1 eq. of chloroacetyl chloride was added, kept stirring at -78°C for 3 h, followed by 
portionwise addition of 3.0 eq. of sodium borohydride at -78°C, then the reaction mixture 
was slowly warmed up to room temperature, and kept vigorously stirring at room 
temperature for 45 min.  At the end of the reaction, THF was evaporated under reduced 
pressure, and a small amount of saturated sodium bicarbonate solution was added into the 
reaction mixture, and extracted with ethyl acetate three times, the organic layer was dried 
over anhydrous sodium sulfate and concentrated under reduced pressure to give the 
reduced N-chloroacetylated oxazoline C20.  Then C20 was dissolved in acetone (C=0.3 
M), and 5.0 eq. of sodium iodide was added, refluxing for 2 h.  At the end of the reaction, 
the reaction mixture was filtered by vacuum filtration, the organic layer was collected and 
concentrated under reduced pressure to give N-iodoacetyl oxazoline C21. 
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Formation of Phenylsulfone C22  
The N-iodoacetyl oxazoline C21 was dissolved in DMF (C=0.2 M), and 1.2 eq. of 
benzene sulfinic acid sodium salt was added, kept vigorously stirring at room temperature  
for 4 h.  At the end of the reaction, a small amount of water was added, and extracted 
with ethyl acetate three times, the organic layer was dried over anhydrous sodium sulfate 
and concentrated under reduced pressure.  The crude mixture was subjected to flash 
column chromatography to give the phenylsulfone C22 (80%) as a white solid.  1H NMR 
(250 MHz) δ 1.90-2.30 (m, 4 H), 2.67 (s, 3 H), 3.72-3.77 (m, 1 H), 3.99-4.04 (m, 2 H), 
4.36-4.38 (d, J=5 Hz, 1 H), 4.04-4.34 (m, 1 H), 5.22-5.24 (m, 1 H), 7.19-7.75 (m, 10 H). 
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Formation of Methyl-(2S)-1-(tert-Butoxycarbonyl) Pyroglutamate C24 
2.0 eq. of thionyl chloride was added dropwise to a cooled solution of L-2-pyrrolidone-5-
carboxylic acid in methanol (C=0.3 M). The mixture was allowed to warm to room 
temperature. After vigorously stirring for 2 h, the solution was evaporated and the residue 
dissolved in dichloromethane, washed with saturated sodium bicarbonate solution, brine, 
and dried over anhydrous sodium sulfate. Evaporation of the organic layer gave methyl-
(S)-pyroglutamate as a crude oil.  A solution of this crude ester, 1.2 eq. of di-tert-butyl-
dicarbonate, and 0.1 eq. of DMAP in acetonitrile (C=0.6M) was stirred for 1h, and the 
residue obtained after removal of the solvent was subjected by flash column 
chromatography to give Methyl-(2S)-1-(tert-Butoxycarbonyl) Pyroglutamate C24 as an 
oil which solidified under vacuo.  1H NMR (250 MHz)  δ 1.37 (s, 9 H), 1.92-2.52 (m, 4 
H), 3.67 (s, 3 H), 4.51 (dd, J1=2.5 Hz, J2=9.1 Hz, 1 H). 
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Formation of Methyl-(2S)-1-(tert-Butoxycarbonyl) Amino Alcohol C25 
Methyl-(2S)-1-(tert-Butoxycarbonyl) Pyroglutamate C24 was dissolved in methanol 
(C=0.2 M), and kept at -10°C, then 10 eq. of sodium borohydride was added, kept stirring 
at -10°C for 1h.  Then the reaction mixture was quenched by saturated sodium 
bicarbonate solution, and extracted with dichloromethane three times.  The organic layer 
was dried over anhydrous sodium sulfate, and concentrated under reduced pressure to 
give the Methyl-(2S)-1-(tert-Butoxycarbonyl) Amino Alcohol C25 as a white oil.  
Conscientious monitoring and stringent control of temperature was crucial in achieving 
the desired selectively reduced amino alcohol, otherwise, side products may ensue. 
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Elimination Product C26 from Methyl-(2S)-1-(tert-Butoxycarbonyl) Amino Alcohol C25 
Methyl-(2S)-1-(tert-Butoxycarbonyl) Amino Alcohol C25 was dissolved in 
dichloromethane (C=0.5 M), 5.0 eq. of TEA was added and kept stirring at -5°C, then 1.2 
eq. of trifluoroacetic anhydride was added, kept stirring at -5°C for 2h.  Then the reaction 
mixture was quenched by addition of a small amount of water, and extracted with 
dichloromethane three times.  The organic layer was dried over anhydrous sodium 
sulfate, and concentrated under reduced pressure.  The crude reaction mixture was 
subjected flash column chromatography to give the elimination product C26 as a white 
oil.  1H NMR (250 MHz)  δ 1.39 (s, 6 H), 1.44 (s, 3 H), 2.63 (dd, J1=14.6, J2=20.2, 1 H), 
2.94-3.10 (m, 1 H), 3.72 (s, 3 H), 4.51-4.65 (m, 1 H), 4.89 (d, J=10.2, 1 H), 6.54 (d, 
J=31.7, 1 H). 
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Formation of Carboxylic Acid C27 by Hydrolysis 
Methyl ester C26 was dissolved in methanol (C=0.2 M), and then 1.5 eq. of 1.0 N. aqueous 
NaOH solution was added, kept stirring at room temperature for 5h.  Then the reaction mixture 
was quenched by slow addition of 2.0 N. HCl, as soon as the reaction mixture turned into weakly 
acidic, ethyl acetate was poured into the reaction mixture, and extracted with ethyl acetate three 
times.  The organic layer was dried over anhydrous sodium sulfate, and concentrated under 
reduced pressure to give carboxylic acid C27 (97%) as a white solid.   
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Formation of the Coupled Product C28 via Coupling Reaction of the Carboxylic Acid C27 
with (S)-(+)-2-phenylglycine methyl ester hydrochloride 
The carboxylic acid C27 was dissolved in anhydrous dichloromethane (C=0.4 M) at 0°C, 
then 1.2 eq. of HOBt was added, followed by addition of 2.4 eq. of TEA, then addition of 
1.2 eq. of EDCI, kept vigorously stirring at 0°C for 1h, finally, the solution of (S)-(+)-2-
phenylglycine methyl ester hydrochloride (dissolved in small amount of anhydrous 
dichloromethane) was added to the reaction mixture.  The reaction mixture was kept 
vigorously stirring at 0°C for 4h. At the end of the reaction, a small amount of water was 
added, and extracted with ethyl acetate three times, the organic layer was dried over 
anhydrous sodium sulfate and concentrated under reduced pressure, then the crude 
mixture was subjected to flash column chromatography to give the coupling product C28 
as a white solid.  1H NMR (250 MHz)  δ 1.45 (s, 9 H), 2.90 (2 H), 3.71 (s, 3 H), 4.60 (1 
H), 5.02 (t, J=1.8, 1 H), 5.56 (d, J=7.2, 1 H), 6.48 (1 H), 7.32 (m, 5 H). 
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Formation of the Reduction Product Phenylglycinol C29 
Methyl ester C28 was dissolved in THF (C=0.4 M) at 0°C, 3.0 eq. of lithium chloride 
was added, kept stirring at 0°C for 5 mins, then 3.0 eq. of sodium borohydride was added 
portionwise, and equal volume of methanol was added dropwise, kept vigorously stirring 
at 0°C for 5 h.  At the end of the reaction, all solvents were evaporated under reduced 
pressure, into the white reaction mixture, a small amount of water was added, and 
extracted with ethyl acetate three times.  The organic layer was dried over anhydrous 
sodium sulfate, and concentrated under reduced pressure to give the reduced product 
phenylglycinol C29 (90%) as a white solid.  1H NMR (250 MHz)  δ 1.48 (s, 6 H), 1.57 (s, 
3H), 2.60 (m, 1 H), 3.00 (m, 2 H), 3.89 (s, 2 H), 4.70 (m, 1 H), 5.10 (t, J=6.3, 1 H), 6.48 
(1 H), 7.30 (m, 5 H). 
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Formation of the Methanesulfonate C30 
Phenylglycinol C29 was dissolved in dichloromethane (C=0.4 M) at -20°C, and 5.0 eq. of 
TEA was added, then 2.3 eq. of methanesulfonyl chloride was added dropwise, kept 
vigorously stirring at -20°C for 4h.  At the end of the reaction, a small amount of water 
was added to quench the reaction mixture, and extracted with dichloromethane three 
times.  The organic layer was dried over anhydrous sodium sulfate, and concentrated 
under reduced pressure to give the product methanesulfonate C30 (90%).  1H NMR (250 
MHz)  δ 1.40 (s, 9 H), 2.72 (m, 1 H), 2.96 (m, 1 H), 3.14 (s, 3 H), 4.07-4.23 (m, 2 H), 
4.72-5.26 (m, 3 H), 6.47 (1 H), 7.30 (m, 5 H). 
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